US healthcare reform must bolster innovation, Lilly CEO says
This article was originally published in Scrip
Executive Summary
Medical innovation is being ignored in the current debate over US healthcare reform and would be undermined by any overhaul that includes a government-run insurance plan, Lilly's chairman and CEO Dr John Lechleiter said.